Organon & Co



Ebitda Cambiamento Data
Bristol-Myers Squibb USD 3.27B 1.63B 2025-06
Celltrion KRW 221.03B 57.43B 2025-03
Cspc Pharmaceutical CNY 2.19B 21.88M 2024-12
Dianthus Therapeutics USD -31838000 1.96M 2024-12
Divis Laboratories Ltd 7.29B 2.43B 2025-06
Gilead Sciences USD 3.4B 797M 2025-06
Glaxosmithkline GBP 1.69B 1.6B 2024-12
Kangmei Pharma -3262057.35 15.91M 2024-09
Knight Therapeutics CAD 16.72M 1.05M 2024-09
Laboratorios Farma EUR 137.9M 93.62M 2024-12
Malin Corporation EUR -1100000 200K 2024-12
Medical Developments International AUD 1.78M 3.78M 2024-12
Merck USD 7.74B 625M 2025-03
Neuren Pharmaceuticals AUD 176.7M 166.79M 2024-12
Novartis USD 6.82B 1.31B 2024-12
Organigram Holdings CAD -16179000 63.98M 2024-12
Organon & Co USD 522M 114M 2025-06
Pharma Mar EUR 26.15M 27.2M 2025-06
Qiagen NV USD 208.98M 38.23M 2025-06
Sartorius EUR 264.3M 1.3M 2025-06
Sino Biopharmaceutical CNY 2.59B 1.57B 2024-12
Tilray USD -101000 2.32M 2024-11


Organon & Co - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Aug 2025.